The FDA proposed a new rule July 23 that, if approved, would establish a statutory annual summary from drugmakers on the use of their drugs under the Right to Try Act.
The Right to Try Act, which was passed in 2017, allows patients with life-threatening diseases to access certain unapproved drugs if they've already tried all approved treatment options and are unable to participate in a clinical trial.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,